"If you are suffering from psoriasis, eczema or other skin diseases, we are seeking volunteers for participation in one of our clinical trials. At Menter Dermatology Research Institute we are constantly adding new clinical trials. Check our website for a list of clinical trial and sign up to receive an email regarding future clinical trials."

During the past decade, Texas Dermatology Research Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Texas Dermatology Research Institute" are "Actinic Keratosis" (1 trials), "Arthritis, Psoriatic" (1 trials), "Basal Cell Carcinoma" (1 trials), "Pain" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Texas Dermatology Research Institute" in a lesser frequency.

Most popular intervention types in "Texas Dermatology Research Institute" are "Drug" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "MM-093" (1 trials), "Onercept" (1 trials), "PDT with Metvix 160 mg/g cream" (1 trials), "PDT with placebo cream" (1 trials) and "Photodynamic therapy with methyl aminolevulinate cream" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Dermatology Research Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Texas Dermatology Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Texas Dermatology Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Texas Dermatology Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".